Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder

BJU International

Volumn 95, Issue 3, 2005, Pages 432-435

  Tsai, Fuu Jen ^a   Chang, Chao Hsiang ^a   Chen, Chang Chung ^a   Hsia, Te Chun ^a   Chen, Huey Yi ^a   Chen, Wen Chi ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bladder cancer; Interleukin 1 and 4; Polymorphism; Transitional cell carcinoma

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER SCREENING; CARCINOGENESIS; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTERLEUKIN 1BETA GENE EXON 5; INTERLEUKIN 4 GENE INTRON 3; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-4; INTRONS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 14144256347     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05315.x     Document Type: Article

References (16)

1. Chiang HS, Hong CL, Quo HR, Lin SM, Lee EF. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol 1993; 71: 274-8
2. Chen WC, Tsai FJ, Wu JY, Wu HC, Lu HF, Li CW. Distribution of p53 codon 72 polymorphism in bladder cancer - proline form is prominent in invasive tumor. Urol Res 2000; 28: 293-6
3. Chen WC, Wu HC, Hsu CD, Chen HY, Tsai FJ. p21 Gene codon 31 polymorphism is associated with bladder cancer. Urol Oncol 2002; 7: 63-6
4. Cantagrel A, Navaux F, Loubet-Lescoulie P et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999; 42: 1093-100
5. Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1 beta gene. J Bone Miner Res 2000; 15: 402-14
6. Sosroseno W, Herminajeng E, Goeno S. The interleukin network in the immunopathogenesis of oral diseases. Asian Pac J Allergy Immunol 1994; 12: 161-8
7. Chandler SW, Rassekh CH, Rodman SM, Ducatman BS. Immunohistochemical localization of interleukin-10 in human oral and pharyngeal carcinomas. Laryngoscope 2002; 112: 808-15
8. Wang YF, Chang SY, Tai SK, Li WY, Wang LS. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck 2002; 24: 850-8
9. Rosenwasser LJ, Klemm DJ, Dresback JK et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 2 (Suppl): 74-8
10. Le Beau MM, Lemons RS, Espinosa R, Larson RA, Arai N, Rowley JD. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 1989; 73: 647-50
11. Mout R, Willemze R, Landegent JE. Repeat polymorphisms in the interleukin-4 gene. Nucl Acids Res 1991; 19: 3763
12. Morisaki T, Yuzuki D, Lin RT, Foshag LJ, Morton DL, Ho DSB. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4. Cancer Res 1992; 52: 6059-65
13. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukwa N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japan. J Gastroenterol 2001; 36: 696-9
14. Arai N, Nomura D, Villaret D et al. Complete nucleotide sequence of the chromosomal gene for IL-4 and its expression. J Immunol 1989; 142: 274-82
15. Seddighzadeh M, Larsson P, Ulfgren AC et al. Low IL-1alpha expression in bladder cancer tissue and survival. Eur Urol 2003; 43: 362-8
16. Kuo JY, Ohmoto Y, Yoshida O. An assessment of interleukin-1 alpha and interleukin-1 beta production in patients with bladder cancer. Anticancer Res 1996; 16 (5B): 3067-70